A brief review of Paxlovid studies
A summary of the literature to date on Paxlovid, by Stephanie Schneck, PharmD, system clinical pharmacy director Please follow this link below to read the overview on NIRMATRELVIR/RITONAVIR, including theLEARN MORE
Injectable promethazine removal from HonorHealth Network Formulary
Injectable promethazine is considered a high-risk medication that can contribute to serious tissue injury and amputation if extravasation occurs. The removal of injectable promethazine from hospital formularies has been anLEARN MORE
Albumin 5% – Critical drug shortage
Albumin 5% 250mL and 500mL presentations are critically short secondary to manufacturing delays. The duration of the shortage is unknown and earliest estimates on resolution are mid-late October 2022. HonorHealthLEARN MORE
- Page 2 of 2
- 1
- 2